» Articles » PMID: 2079636

Inhibitory Effect of Di- and Tripeptidyl Aldehydes on Calpains and Cathepsins

Overview
Journal J Enzyme Inhib
Specialty Biochemistry
Date 1990 Jan 1
PMID 2079636
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Eight different di- and tripeptidyl aldehyde derivatives, each having at its C-terminus an aldehyde analog of L-norleucine, L-methionine, or L-phenylalanine with a preceding L-leucine residue, were synthesized and tested for their inhibitory effects on several serine and cysteine endopeptidases. These compounds showed almost no inhibition of trypsin, and only weak inhibition of alpha-chymotrypsin and cathepsin H, while they exhibited marked inhibition of cathepsin B less than calpain II congruent to calpain I less than cathepsin L, being stronger in this order. The mode of inhibition of these cysteine proteinases was competitive for the peptide substrate used and inhibitor constants (Ki) were calculated from the Dixon plot. The best inhibitors found were: 4-phenyl-butyryl-Leu-Met-H for calpain I (Ki, 36 nM) and calpain II (Ki, 50 nM); acetyl-Leu-Leu-nLeu-H for cathepsin L (Ki, 0.5 nM); acetyl-Leu-Leu-Met-H for cathepsin B (Ki, 100 nM).

Citing Articles

Cathepsins L and B target HIF1α for oxygen-independent proteolytic cleavage.

Stuart S, Tarade D, Ohh M Sci Rep. 2024; 14(1):14799.

PMID: 38926538 PMC: 11208597. DOI: 10.1038/s41598-024-65537-9.


Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors.

Falke S, Lieske J, Herrmann A, Loboda J, Karnicar K, Gunther S J Med Chem. 2024; 67(9):7048-7067.

PMID: 38630165 PMC: 11089505. DOI: 10.1021/acs.jmedchem.3c02351.


The roles of intracellular proteolysis in cardiac ischemia-reperfusion injury.

Hartley B, Bassiouni W, Schulz R, Julien O Basic Res Cardiol. 2023; 118(1):38.

PMID: 37768438 DOI: 10.1007/s00395-023-01007-z.


Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy.

Yang W, Li Q, Sun J, Huat Tan S, Tang Y, Zhao M Comput Struct Biotechnol J. 2022; 20:2442-2454.

PMID: 35602976 PMC: 9110316. DOI: 10.1016/j.csbj.2022.05.023.


Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease.

Sarkar A, Mandal K Angew Chem Int Ed Engl. 2021; 60(44):23492-23494.

PMID: 34545983 PMC: 8652770. DOI: 10.1002/anie.202107481.